RSM logo
International Journal of STD & AIDS

Home Current issue Browse archive Alerts About the journal Feedback
 
Int J STD AIDS 2008;19:642-643
doi:10.1258/ijsa.2008.008062
© 2008 Royal Society of Medicine Press

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leng, K
Right arrow Articles by Hartmann, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Case reports

Fatal outcome of nevirapine-associated toxic epidermal necrolysis

K Leng MD * , A Lonsdorf MD {dagger} and M Hartmann MD *

* Department of Dermatology, University of Heidelberg, Germany; {dagger} Dermatology Branch, Center for Cancer Research, NCI, Bethesda, USA

Correspondence to: Dr Med Katharina Leng, Universitäts-Hautklinik, Voßstraße 2, 69115 Heidelberg, Germany Email: katharina.leng{at}med.uni-heidelberg.de

The irregular use of antiretroviral therapy (ART) can result in ART-resistance but can also lead to a sensitization between agents with a cross-sensitivity. We report a case of nevirapine-associated toxic epidermal necrolysis resulting in death in an HIV-infected man.

Key Words: HIV • nevirapine • TEN • rash


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




MDU Exam Doctor